Skip to main content
TeamingIndex
Unclaimed profileSeeded from SAM.gov and USAspending public records
Claim this profileCapability statement (.md)

CERUS CORPORATION

UEIKJJQRRLY2FL5CAGE1PVJ6NAICS325413
  • SAM active
  • No verified credentials yet
  • CMMCNot on file
  • SPRSNone
  • FCLVisible to paid members

Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works

36-mo obligations
$264M
Awards on record
25
Contract vehicles
0
Verified credentials
0

Compliance posture: unverified (SAM.gov baseline only)

CERUS CORPORATION has not claimed this profile. What you see comes from public SAM.gov and USAspending records; no one from the company has confirmed CMMC, SPRS or clearance details yet. Learn more about CMMC 2.0

Claim this profile

About CERUS CORPORATION

CERUS CORPORATION is a SAM.gov-registered entity based in CONCORD, CA 94520-4906. UEI KJJQRRLY2FL5; CAGE 1PVJ6; primary NAICS 325413. Compliance posture not provided. Active SAM registration.
Headquarters
CONCORD, CA 94520-4906

Identifiers

UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.

  • UEIKJJQRRLY2FL5
  • CAGE1PVJ6

Capabilities & differentiators

No capability narrative yet

The company has not published a capability narrative. Its SAM.gov registration, NAICS codes and award history are below.
Is this your company? Claim it

Compliance posture

Every credential shows who vouches for it: verified by TeamingIndex, or self-attested by the contractor.

No compliance posture published yet

Compliance facts appear once the company claims this profile and publishes them.
Is this your company? Claim it

Facility clearance

Facility clearance: visible to paid members

Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans

Past performance

Recompete RadarLearn more about past performance
Prime awards from USAspending.gov (FPDS), synced nightly. Recompete windows use the potential end date (base plus all options).
36-month obligations
$264M
Awards on record
25
Top funding agencies
Office of Assistant Secretary for Preparedness and Response · Food and Drug Administration · Defense Health Agency

Awards

  • 75A50124C00046

    Recompete 18+ mo: Potential end Sep 30, 2031 (58 months away)

    LICENSE PATHOGEN REDUCTION TECHNOLOGY (PRT) FOR RED BLOOD CELL (RBC) COMPONENTS TO REDUCE THE RISK OF TRANSFUSION-TRANSMITTED INFECTION…

    Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response

    Obligated
    $65.4M
    Period of performance
    Sep 30, 2024 – Sep 30, 2031

  • W81K0225PA067

    Recompete 6–12 mo: Potential end Sep 30, 2027 (10 months away)

    CERUS INTERCEPT PLATELET PROCESSING SETS

    Department of Defense · Defense Health Agency

    Obligated
    $71.6K
    Period of performance
    Oct 1, 2025 – Sep 30, 2027
    AI brief for award W81K0225PA067Bid team for the recompete of award W81K0225PA067

  • HT941024P0214

    Recompete 6–12 mo: Potential end Sep 30, 2027 (10 months away)

    INTERCEPT PLATELET PROCESSING KITS

    Department of Defense · Defense Health Agency

    Obligated
    $153.3K
    Period of performance
    Oct 1, 2024 – Sep 30, 2027
    AI brief for award HT941024P0214Bid team for the recompete of award HT941024P0214

  • HT941024P0239

    Recompete 6–12 mo: Potential end Sep 30, 2027 (10 months away)

    SERVICE MAINTENANCE CERUS ILLUMINATOR

    Department of Defense · Defense Health Agency

    Obligated
    $30.4K
    Period of performance
    Oct 1, 2024 – Sep 30, 2027
    AI brief for award HT941024P0239Bid team for the recompete of award HT941024P0239

  • HT940624P0092

    Recompete 6–12 mo: Potential end Sep 26, 2027 (10 months away)

    ILLUMINATOR MAINTENANCE

    Department of Defense · Defense Health Agency

    Obligated
    $15.1K
    Period of performance
    Sep 27, 2024 – Sep 26, 2027
    AI brief for award HT940624P0092Bid team for the recompete of award HT940624P0092

  • HT001424P0164

    Recompete 6–12 mo: Potential end Jun 18, 2027 (7 months away)

    INTERCEPT BLOOD SYSTEM FOR PLATELETS AND PLASMA PATHOGEN REDUCTION SYSTEM AT ARMED SERVICES BLOOD BANK.

    Department of Defense · Defense Health Agency

    Obligated
    $218.3K
    Period of performance
    Jul 8, 2024 – Jun 18, 2027
    AI brief for award HT001424P0164Bid team for the recompete of award HT001424P0164

  • W81K0024P0073

    Recompete < 6 mo: Potential end Apr 30, 2027 (5 months away)

    INT100: ILLUM INTRCPT MTNC FEE (BY)

    Department of Defense · Department of the Army

    Obligated
    $7.1K
    Period of performance
    May 1, 2024 – Apr 30, 2027
    AI brief for award W81K0024P0073Bid team for the recompete of award W81K0024P0073

  • HHSO100201600009C

    Recompete < 6 mo: Potential end Mar 31, 2027 (4 months away)

    CERUS - DEVELOPMENT AND IMPLEMENTATION OF PATHOGEN REDUCTION TECHNOLOGY (PRT). IGF::OT::IGF

    Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response

    Obligated
    $185.2M
    Period of performance
    Jun 17, 2016 – Mar 31, 2027
    AI brief for award HHSO100201600009CBid team for the recompete of award HHSO100201600009C

  • HT940625P0009

    Recompete < 6 mo: Potential end Feb 23, 2027 (3 months away)

    INT2540B DROP SHIPMENT FOR PLATELET PROCESSING

    Department of Defense · Defense Health Agency

    Obligated
    $142.2K
    Period of performance
    Feb 21, 2025 – Feb 23, 2027
    AI brief for award HT940625P0009Bid team for the recompete of award HT940625P0009

  • HT941025P0036

    Recompete < 6 mo: Potential end Feb 8, 2027 (2 months away)

    ILLUMINATOR ANNUAL PREVENTIVE MAINTENANCE

    Department of Defense · Defense Health Agency

    Obligated
    $45.4K
    Period of performance
    Jan 28, 2025 – Feb 8, 2027
    AI brief for award HT941025P0036Bid team for the recompete of award HT941025P0036

  • 75N98026P00071

    Completed: Period of performance ended Nov 8, 2026

    (R) CERUS CORPORATION:1188061 [26-000202]

    Department of Health and Human Services · National Institutes of Health

    Obligated
    $225.3K
    Period of performance
    Mar 9, 2026 – Nov 8, 2026

  • HT941025P0011

    Completed: Period of performance ended Sep 30, 2026

    INTERCEPT PLATELET PROCESSING SET AND SERVICE MAINTENANCE

    Department of Defense · Defense Health Agency

    Obligated
    $128.5K
    Period of performance
    Jan 14, 2025 – Sep 30, 2026

  • W81K0024P0026

    Completed: Period of performance ended Sep 30, 2026

    INTERCEPT PLATELET SET PN INT2140B

    Department of Defense · Department of the Army

    Obligated
    $108.4K
    Period of performance
    Jan 5, 2024 – Sep 30, 2026

  • HT941024P0146

    Completed: Period of performance ended Sep 1, 2026

    INTERCEPT PLATELET SMALL VOLUME SETS

    Department of Defense · Defense Health Agency

    Obligated
    $74K
    Period of performance
    Jul 1, 2024 – Sep 1, 2026

  • 75N90025P00572

    Completed: Period of performance ended Jul 14, 2026

    INTERCEPT BLOOD SYSTEM ILLUMINATORS PREVENTATIVE MAINTENANCE AGREEMENT: PERIOD OF PERFORMANCE: 07/15/2025-07/14/2025

    Department of Health and Human Services · National Institutes of Health

    Obligated
    $15.4K
    Period of performance
    Jul 15, 2025 – Jul 14, 2026

  • 75N90025P00719

    Completed: Period of performance ended Sep 30, 2025

    25-007944 INTERCEPT PLATELET PROCESSING SETS

    Department of Health and Human Services · National Institutes of Health

    Obligated
    $115.9K
    Period of performance
    Sep 12, 2025 – Sep 30, 2025

  • 75N90025P00355

    Completed: Period of performance ended Sep 30, 2025

    INTERCEPT PLATELET PROCESSING SET WITH DUAL STORAGE CONTAINERS FOR THE DEPARTMENT OF TRANSFUSION MEDICINE.

    Department of Health and Human Services · National Institutes of Health

    Obligated
    $28.9K
    Period of performance
    Apr 1, 2025 – Sep 30, 2025

  • W81K0221P0132

    Completed: Period of performance ended Sep 30, 2025

    INTERCEPT PLATELET PATHOGEN REDUCTION SETS AT TAMC, HI

    Department of Defense · Department of the Army

    Obligated
    $258.2K
    Period of performance
    Oct 1, 2021 – Sep 30, 2025

  • 75F40120C00158

    Completed: Period of performance ended Sep 28, 2025

    BAA PROPOSAL EETWP33 DEVELOPMENT OF AN OPTIMIZED PATHOGEN INACTIVATION PROCESS FOR WHOLE BLOOD

    Department of Health and Human Services · Food and Drug Administration

    Obligated
    $11.1M
    Period of performance
    Sep 24, 2020 – Sep 28, 2025

  • 75N90025P00456

    Completed: Period of performance ended Jun 7, 2025

    (R) CERUS CORPORATION:1188061 [25-006114]

    Department of Health and Human Services · National Institutes of Health

    Obligated
    $14.9K
    Period of performance
    May 7, 2025 – Jun 7, 2025

  • N0025920P0120

    Completed: Period of performance ended Feb 8, 2025

    SERVICE MAINTENANCE TWO(2)CONTRACT ILLUMINATORS FOR BASE YEAR PLUS 4 OPTION YEARS.

    Department of Defense · Defense Health Agency

    Obligated
    $82.8K
    Period of performance
    Feb 7, 2020 – Feb 8, 2025

  • N0025921P0334

    Completed: Period of performance ended Sep 30, 2024

    INT PLATELET SET-SMALL, PART NO INT2130B

    Department of Defense · Department of the Navy

    Obligated
    $218.4K
    Period of performance
    Aug 27, 2021 – Sep 30, 2024

  • N0025919P0418

    Completed: Period of performance ended Sep 3, 2024

    INTERCEPT PLATELET SMALL VOLUME SET

    Department of Defense · Defense Health Agency

    Obligated
    $104.3K
    Period of performance
    Sep 30, 2019 – Sep 3, 2024

  • N6264520P0024

    Completed: Period of performance ended May 12, 2024

    INTERCEPT PLATELET PROCESSING SET

    Department of Defense · Defense Health Agency

    Obligated
    $233.4K
    Period of performance
    May 13, 2020 – May 12, 2024

  • HT940624P0032

    Completed: Period of performance ended Jan 1, 2024

    DROP SHIPMENT OF INTERCEPT DUAL

    Department of Defense · Defense Health Agency

    Obligated
    $66.6K
    Period of performance
    Jan 1, 2024 – Jan 1, 2024

Contract vehicles

Learn more about GWACs, IDIQs and contract vehicles

No contract vehicles on file

This company has not listed GWAC, IDIQ, GSA Schedule or OTA consortium holdings.
Browse vehicle holders

Proven teaming graph

Learn more about sub-award reporting (FSRS)
Who CERUS CORPORATION has actually worked with, from sub-awards that prime contractors report to the government. Use it to see which primes already trust this company.

No sub-award reports yet

Prime contractors report first-tier subcontracts of $30,000 or more. None name this company yet, which is common for companies that mostly win prime contracts or work below the reporting threshold.
See where agencies spend

Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.

SBIR/STTR portfolio

Learn more about SBIR/STTR Phase IIIAbout SBIR/STTR (opens in a new tab)
Small Business Innovation Research and Technology Transfer awards: early-stage federal R&D money this company has won.

SBIR/STTR awardee — Phase III-eligible for work derived from its SBIR/STTR projects

Agencies may award follow-on Phase III work without a new competition when it builds on this company’s earlier SBIR/STTR projects. Other work is competed as usual.

Awards on record
14 awards
Total awarded
$3,535,972
By phase
  • SBIR Phase I: 11
  • SBIR Phase II: 2
  • STTR Phase I: 1
By agency
  • Department of Health and Human Services: 14
By year
  • 2006: 2
  • 2005: 2
  • 2004: 4
  • 2003: 6

Awards (most recent first)

  • Vaccine-enhanced DLI to prevent cancer recurrence after stem cell transplantation

    STTR Phase I · Department of Health and Human Services (National Institutes of Health) · 2006 · $100,000

    Research partner: EMORY UNIVERSITY

  • Vaccine-enhanced DLI to prevent cancer recurrence after stem cell transplantation

    SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2006 · $100,000

    Solicitation PHS2006-2 (2006)

  • Listeria-Based Ovarian Cancer Polyepitope Vaccines

    SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2005 · $559,626

    Solicitation PHS2005-2 (2005)

  • Listeria Immunotherapy for Pancreatic and Ovarian Cancer

    SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2005 · $1,127,740

    Solicitation PHS2005-2 (2005)

  • Amotosalen PCT of Leukapheresis Units for GvHD Therapy

    SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2004 · $100,000

    Solicitation PHS2004-2 (2004)

  • MINIATURIZED INSTRUMENTATION FOR THE HTS OF DNA REPAIR

    SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2004 · $100,000

    Solicitation PHS2004-2 (2004)

  • Listeria-CEA Vaccine-Infected DC for Cancer Therapy

    SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2004 · $100,000

    Solicitation PHS2004-2 (2004)

  • Validation of Amotosalen-HCI for Clinical Use

    SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2004 · $748,606

    Solicitation PHS2004-2 (2004)

  • Use of Listeria as Colon Cancer Vaccine Adjuvants

    SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2003 · $100,000

  • Listeria-Based Vaccines for Ovarian Cancer Therapy

    SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2003 · $100,000

  • DNA Repair Inhibition and Cancer Therapy

    SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2003 · $100,000

  • Cord Blood Stem Cell Transplantation, Hemoglobinopathies

    SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2003 · $100,000

  • Stem Cell Transplantation for Hemoglobinopathies in Dogs

    SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2003 · $100,000

  • Validation of Amotosalen-HCI for Clinical Use

    SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2003 · $100,000

Source: SBIR.gov award data file (opens in a new tab) · as of Nov 12, 2026 · file published Nov 1, 2026

FedRAMP offerings

Learn more about the FedRAMP Marketplace
Cloud services this company lists on the FedRAMP Marketplace, the government's record of cloud authorizations.

No FedRAMP Marketplace listing

No FedRAMP Marketplace listing is linked to this company. Cloud providers appear here automatically once FedRAMP lists their offering.
Find FedRAMP-authorized companies

Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded

Exclusions & screening

Exclusions about SAM.gov exclusionsScreening list about the Consolidated Screening List
Checks a prime runs before teaming: SAM.gov exclusions (debarment and suspension) and the government's Consolidated Screening List for export and sanctions lists.

SAM.gov exclusions

Not yet checked against SAM.gov exclusions.

Search exclusions on SAM.gov (opens in a new tab)

Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.

Source: SAM.gov Exclusions (opens in a new tab) · sync date not recorded

Consolidated Screening List

No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).

The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.

Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 13, 2026

GSA CALC+ rate benchmark

Learn more about GSA CALC+ labor rates
Hourly ceiling rates this company was awarded on GSA contracts, compared with the market for similar labor categories. Ceiling rates are the most an agency can be charged, not prices paid.

No GSA CALC+ rates on record

Companies with a GSA Multiple Award Schedule contract appear here after CALC+ publishes their awarded labor rates.
See GSA MAS holders

Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded

NAICS, PSC & socio-economic status

Learn more about NAICS size standards
Industry codes and small-business programs reported in SAM.gov.

NAICS codes

  • 325413Title not in the curated listPrimary
  • 325412Pharmaceutical Preparation Manufacturing
  • 334510Electromedical and Electrotherapeutic Apparatus Manufacturing
  • 334516Analytical Laboratory Instrument Manufacturing
  • 339112Surgical and Medical Instrument Manufacturing
  • 339113Surgical Appliance and Supplies Manufacturing
  • 811210Electronic and Precision Equipment Repair and Maintenance

SAM.gov does not report this entity as small under any listed NAICS code.

Socio-economic status

No socio-economic certifications reported in SAM.gov.

Product & service codes (PSC)

No PSC codes reported.

Teaming preferences

Learn more about teaming agreements and joint ventures

This company has not published teaming preferences.

SAM.gov teaming eligibility: Eligible to be proposed as a team member: active SAM.gov registration and no exclusion.

Business development contact

No BD contact published

Contact details appear once the company claims this profile.
Is this your company? Claim it

Corporate hierarchy

Affiliation & size about affiliation and size
Immediate parent and highest-level owner as reported in SAM.gov.

No parent entity reported in SAM.gov.

SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.

Data sources & provenance

Who stands behind each fact on this page, and how to correct it.

  • SAM.gov

    Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.

  • USAspending.gov

    Prime award history and obligations (FPDS), synced nightly.

  • The contractor

    Nothing yet: this profile has not been claimed by the company.

  • TeamingIndex verification

    Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.

Corrections

Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)

Machine-readable: capability.md schema.org JSON-LD embedded in this page.

Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.

Teaming

Ready to team with CERUS CORPORATION?

Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.

Claim this profileCapability statement (.md)